ESG Investing Conference

Impact Investing Conference

ESG Investing

BD Launches New ‘Together We Advance’ Environmental, Social, Governance Strategy; Announces 2030+ Goals to Enhance Stewardship of Human Health, Communities and the Planet PRNewswireBD Launches New ‘Together We Advance’ Environmental, Social, Governance Strategy; Announces 2030+ Goals to Enhance Stewardship of Human Health, Communities and the Planet PRNewswireBD Launches New ‘Together We Advance’ Environmental, Social, Governance Strategy; Announces 2030+ Goals to Enhance Stewardship of Human Health, Communities and the Planet PRNewswire

Impact Investing Conference

Impact Investing Forum 2023

London. Dec 05-06, 2023.

Book Now! 

Building on more than two decades of achievements, BD making bold ESG commitments to advance the world of health for all BD (Becton, Dickinson and Company). Oct 18, 2021, 06.00 ET FRANKLIN LAKES, N.J., October 18, 2021 /PRNewswire/ — BD, a leading global medical tech company, announced today a new strategy to promote environmental, social and governance initiatives. It also announced a set of goals for 2030 and beyond that focuses on improving stewardship of the community, and the company, and the planet, and the company, and the environment, and the company, and the planet, and the company, and the company, and the company, and the company, and the company, and the planet, the community and the overall stewards. Today, BD announced a new strategy to promote environmental, social, and governance (ESG), as well as a set of goals for 2030 and beyond that focuses on improving stewardship of the company and the planet, community, and human health. “Together We Advance” ESG Strategy
Together We Advance is BD’s ESG strategy. It serves as a framework for the company to address the most important ESG issues it faces and those of its stakeholders. The new approach builds upon BD’s core Purpose – advancing the world health – and focuses its efforts on four key pillars: CompanyHealth: Building a solid business foundation through good governance, transparent reporting, and company health. Planet Health: Developing sustainable solutions to reduce the company’s environmental footprint. Community Health: Working with communities to find solutions and investing company resources in the right direction. Human Health: Enabling employees to invent new products and solutions that will improve health care. Tom Polen, chairman, CEO, and president of BD, stated that a new ESG strategy is being implemented to build on our commitments to improve and advance individual health and public health globally. We know that the health and well-being of our company, our planet and the communities we serve is directly linked. When we address one, we often solve problems in the other. These interconnections are what Together We Advance aims to embrace. Our ultimate goal is to create a world that is resilient and healthy for all. “2030+ Goals and Impact Areas
Under BD’s Together We Advance strategy, the company has made commitments in five areas that are most important to its stakeholders and where the company has identified opportunities to create meaningful, measurable change across the pillars of health over the next decade — Climate Change, Product Impacts, Responsible Supply Chain, Healthy Workforce and Communities, and Transparency. These five areas connect across and advance the four pillars of the ESG strategy, each impacting the health of the company, planet, communities and people. The company established a set of goals in each area to achieve by 2030 (and beyond) to measure its success in driving positive health outcomes across its ESG strategy and continue its commitment to help achieve UN Sustainable Development Goals (SDGs). “We developed our 2030 ESG goals by challenging ourselves to think about where we can make the greatest impact on our industry, society and planet today,” Polen added. “We are prioritizing climate change through reducing emissions and integrating climate impact considerations into our business strategy, while also addressing the impact of our products and resiliency of the supply chain. We are acting immediately on these commitments. For example, we recently signed onto the United Nations Race to Zero campaign, where BD now joins the largest alliance dedicated to achieving net zero carbon emissions by 2050 or sooner. We will also continue to demonstrate how an ethical, sustainable and inclusive company can drive growth while supporting our global communities for generations to come.”The 2030+ goals include:Climate Change: Reducing Scope 1 and 2 greenhouse gas (GHG) emissions 46% by 2030 (from a 2019 baseline) and achieving carbon neutrality across direct operations by 2040. The company also committed to set targets to reduce Scope 3 emissions. Product Impacts: Reducing the environmental impact of the company’s product portfolio by addressing plastic and packaging material consumption and the impact of plastics throughout its value chain through considerations in product design; and reducing Scope 3 emissions from use and disposal of products in line with 1.5?C emissions scenarios. Responsible Supply Chain: Working with supply chain partners to quantify and reduce Scope 3 emissions in line with 1.5?C emissions scenarios, in addition to strengthening engagement with supply chain partners on their labor and environmental practices and performance. Healthy Workforce and Communities: Empowering employees to manage their physical, mental and financial health and committing to improving ethnic and gender diversity by 1% year over year at the management and executive levels. Transparency: Reporting clear information around performance and progress toward the company’s ESG goals through its annual sustainability report. BD will do this in alignment with recognized external ESG reporting frameworks, including the Task Force for Climate Related Financial Disclosures (TCFD) and Sustainability Accounting Standards Board (SASB). For more information about the company’s ESG strategy and 2030+ goals, visit BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at and Twitter @BDandCo.Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Many of these risks and uncertainties are beyond the company’s control, including without limitation, challenges relating to economic, competitive, governmental, and technological factors affecting our operations, markets, and products, and other factors listed in our 2020 Annual Report on Form 10-K and other filings with the SEC. BD expressly disclaims any undertaking to update or revise any forward-looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation. Contacts:
Media Investors
Troy Kirkpatrick Kristen M. Stewart, CFA VP, Public Relations SVP, Investor Relations 858-617-2361 201.847.5378 [email protected] [email protected] SOURCE BD (Becton, Dickinson and Company) Related Links

Modal title BD Unveils Nebraska’s Manufacturing Capacity to Support U.S BD Announces 510 (k) Clearance Expanded Indications

Read More

Impact Investing Conference


Leave a Reply

Your email address will not be published. Required fields are marked *

ESG Investing Conference

Generated by Feedzy